sldb: the income statement

MyFinsight

Solid Biosciences Inc. (SLDB)

For the quarter ending 2025-06-30, SLDB made $3,173K in revenue. -$39,480K in net income. Net profit margin of -1244.25%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30
Research and development	32,415	30,914	27,327
General and administrative	9,278	9,138	7,855
Total operating expenses	41,693	40,052	35,182
Loss from operations	-41,693	-40,052	-35,182
Other income, net	207	188	211
Interest income	2,966	2,300	2,328
Interest expense	60	68	82
Change in fair value of derivative liabilities	-900	-1,650	-
Total other income, net	2,213	770	2,457
Net loss	-39,480	-39,282	-32,725

Earnings per share, basic, total	-0.42	-0.59	-0.79
Earnings per share, diluted, total	-0.42	-0.59	-0.79
Weighted average number of shares outstanding, basic, total	94,140,286	66,341,305	41,443,317
Weighted average number of shares outstanding, diluted, total	94,140,286	66,341,305	41,443,317

Unit: Thousand (K) dollars (except for numbers of shares and EPS)